CA 19-9 in follow-up of patients with colorectal cancer: Should it stay or should it go ?

J BUON. 2019 May-Jun;24(3):1310-1311.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • CA-19-9 Antigen / blood*
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / pathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Prognosis

Substances

  • CA-19-9 Antigen